C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in C4 Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- −4 vs. Q3 2024
- Shares held
- 64.4M
- +219.7K (+0.3%) vs. Q3 2024
- Total value
- $231.8M
- −$134.0M (−36.6%) vs. Q3 2024
- New holders
- 25
- 38 more added
- Sold out
- 29
- 33 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $547.6M |
| Q1 2026 | 123 | $221.3M |
| Q4 2025 | 101 | $152.5M |
| Q3 2025 | 97 | $116.6M |
| Q2 2025 | 102 | $78.2M |
| Q1 2025 | 115 | $102.6M |
| Q4 2024 | 113 | $231.8M |
| Q3 2024 | 118 | $365.9M |
| Q2 2024 | 115 | $281.3M |
| Q1 2024 | 106 | $475.6M |
| Q4 2023 | 92 | $265.6M |
| Q3 2023 | 84 | $64.5M |
| Q2 2023 | 100 | $94.1M |
| Q1 2023 | 121 | $117.5M |
| Q4 2022 | 117 | $231.4M |
| Q3 2022 | 114 | $345.9M |
| Q2 2022 | 113 | $297.2M |
| Q1 2022 | 125 | $904.8M |
| Q4 2021 | 119 | $1.15B |
| Q3 2021 | 113 | $1.54B |
| Q2 2021 | 107 | $1.21B |
| Q1 2021 | 83 | $926.8M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding C4 Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ArrowMark Colorado Holdings LLC | 1,334,101 | $4.80M | 0.06% | +14,617+1.1% | Added |
| Geode Capital Management, LLC | 1,381,086 | $4.97M | 0.00% | +11,410+0.8% | Added |
| Adage Capital Partners GP, L.L.C. | 1,550,000 | $5.58M | 0.01% | +1,030,000+198.1% | Added |
| Bank of America Corp | 1,677,642 | $6.04M | 0.00% | −358,591−17.6% | Reduced |
| Samlyn Capital, LLC | 3,019,458 | $10.9M | 0.17% | +3,019,458 | New |
| Vanguard Group Inc | 3,345,973 | $12.0M | 0.00% | −24,708−0.7% | Reduced |
| Morgan Stanley | 3,839,469 | $13.8M | 0.00% | +1,513,335+65.1% | Added |
| OrbiMed Advisors LLC | 4,377,900 | $15.8M | 0.33% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,878,000 | $17.6M | 0.23% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,558,851 | $20.0M | 0.00% | +667,916+13.7% | Added |
| Wasatch Advisors Inc | 6,072,601 | $21.9M | 0.11% | +395,233+7.0% | Added |
| Lynx1 Capital Management LP | 6,852,744 | $24.7M | 9.25% | −27,783−0.4% | Reduced |
| Soleus Capital Management, L.P. | 6,978,942 | $25.1M | 1.90% | +374,946+5.7% | Added |
| Commodore Capital LP | 0 | $0 | 0.00% | −3,410,384−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −266,159−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −147,874−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −143,855−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −138,899−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −134,636−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −84,951−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −73,350−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −43,400−100.0% | Sold out |
| Hussman Strategic Advisors, Inc. | 0 | $0 | 0.00% | −42,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −39,180−100.0% | Sold out |
| Vestcor Inc | 0 | $0 | 0.00% | −29,500−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −28,436−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −24,941−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −15,446−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −14,344−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −12,025−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −11,791−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −11,620−100.0% | Sold out |
| Cynosure Management, LLC | 0 | $0 | 0.00% | −10,007−100.0% | Sold out |
| Morgan Dempsey Capital Management LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −1,018−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −530−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −143−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Planning Capital Management Corp | – | – | – | – | Not filed |